Joel Cavaness
About Joel D. Cavaness
Independent, non‑executive director of James River Group Holdings, Ltd. (JRVR) since July 2025; age 64 as of September 3, 2025. Nearly four decades in specialty P&C distribution, most recently divisional Chairman at Arthur J. Gallagher & Co. and co‑founder/President of Risk Placement Services (RPS). Holds a B.S. in Business Administration from Southeast Missouri State University and professional designations CPCU and ARM. The Board has determined he is independent under Nasdaq standards.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Arthur J. Gallagher & Co. | Divisional Chairman, Americas Specialty | Through June 2025 | Executive leadership across wholesale brokerage; distribution relationships in surplus lines |
| Risk Placement Services (RPS), subsidiary of Gallagher | Co‑Founder and President; later senior leadership | 1997–2024 | Built/led wholesale distribution platform; specialty E&S focus |
| International Special Risk Services, Inc. | President | 1996–1997 | Specialty insurance leadership |
| Crum & Forster Insurance Company (and other insurers) | Underwriting roles | Early career | Technical underwriting foundation |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Wholesale & Specialty Insurance Association (WSIA) | Director | 2010–2022 | Received WSIA’s Vincent Donahue/Charles McAlear Industry Award (2023) |
Board Governance
- Current JRVR roles: Director; member, Compensation & Human Capital Committee (Chair: Peter B. Migliorato; members: Joel D. Cavaness, Christine LaSala). Not a committee chair.
- Independence: Board affirmed independence of Cavaness under Nasdaq standards.
- Board structure and oversight: Non‑Executive Chair (Christine LaSala) since Feb 2025; Audit Committee oversees financial, cybersecurity and related‑party risks; Audit meets without management at least quarterly.
- Director nomination: Identified via an independent search firm retained by the Nominating & Corporate Governance Committee.
- Attendance benchmark: In 2024 (pre‑appointment), Board held four in‑person meetings and all directors met the ≥75% attendance threshold; committees also met regularly. (Context; not specific to Cavaness given his 2025 appointment.)
Fixed Compensation
| Component | Amount/Terms | Applicability to Cavaness |
|---|---|---|
| Annual cash retainer (non‑employee directors) | $125,000 per year | Payable to non‑employee directors, including Mr. Cavaness |
| Equity retainer (RSUs) | $50,000 grant date fair value; Chair receives $100,000 | Time‑vested; eligible on a pro‑rated basis for mid‑year appointees like Mr. Cavaness |
| Committee chair fees | Audit Chair: $25,000; Comp Chair: $12,500; Nominating Chair: $12,500 | Not applicable (not a chair) |
| Pro‑rata equity for new directors | Pro‑rated RSUs vesting on first anniversary of standard grant date | Applies to mid‑2025 appointment |
- Form 8‑K confirms Mr. Cavaness will receive the same cash and equity compensation as other non‑employee directors.
Performance Compensation
| Type | Terms | Notes |
|---|---|---|
| Performance‑based awards for directors | None disclosed | Non‑employee directors receive time‑vested RSUs; no performance metrics tied to director pay |
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public company directorships | None disclosed for Mr. Cavaness |
| Prior public boards | Not disclosed (industry association board noted above) |
| Interlocks/conflicts | Form 8‑K states no Item 404(a) related‑party transactions; no arrangement/understanding underlying appointment. Audit Committee reviews/approves related‑party transactions. |
Expertise & Qualifications
- Deep specialty P&C distribution expertise; co‑founded and scaled RPS; executive leadership across wholesale brokerage.
- Professional designations CPCU and ARM; B.S. Business Administration.
- Board skills matrix indicates all directors, including Cavaness, bring Insurance Industry Expertise and Corporate Governance capabilities.
- Governance signal: Identified by independent search; independence affirmed.
Equity Ownership
| Item | Status |
|---|---|
| Beneficial ownership (common) | No common shares beneficially owned as of Sept 3, 2025; name listed with “—” in table. |
| Shares outstanding context | 45,922,507 common shares outstanding as of Sept 3, 2025. |
| Ownership guidelines | Non‑employee directors: 3x annual cash retainer within 5 years; must retain 100% of net shares for 1 year post‑vesting and 75% thereafter until compliant. |
| Hedging/pledging | Prohibited for directors under insider trading policy. |
Governance Assessment
-
Positives
- Independent director with highly relevant distribution expertise; brings relationships and operational insight to E&S‑focused strategy.
- Immediate placement on Compensation & Human Capital Committee; committee retains independent adviser (Aon) and had independence affirmed by the Board.
- Strong shareholder alignment frameworks: director ownership guidelines (3x retainer), anti‑hedging/pledging policy, annual board/committee evaluations.
- No related‑party transactions disclosed for his appointment; Audit Committee oversees related‑party approvals.
- Say‑on‑pay support at 97.3% in 2024 indicates broad investor confidence in compensation governance (broader signal for comp committee environment).
-
Watch items
- New appointee with no disclosed JRVR share ownership yet; guideline compliance period allows up to five years, but near‑term “skin‑in‑the‑game” may be limited until equity is acquired/vested.
- Background from a major wholesale broker (Gallagher/RPS) creates potential channel‑conflict optics; however, company disclosed no Item 404(a) related‑party transactions and has policies/committee oversight to manage conflicts.
Overall implication: Cavaness enhances board effectiveness in JRVR’s core E&S franchise while governance structures (independence, conflict‑review, director ownership rules) mitigate conflict risks. Near‑term ownership alignment should improve as pro‑rated director RSUs vest and as he advances toward the 3x retainer guideline.